About this trial
Obstructive Sleep Apnea (OSA) affects quality of life and health. Mandibular Advancement Devices (MAD) can help with OSA but may cause dental and jaw changes. This study uses a new 3D scanning method to track these changes and compare two adjustment methods for MAD to find the best approach for patients.
Goals:
1. To track dental and jaw changes in OSA patients using 3D scans. 2. To assess the impact of MAD on quality of life and cognitive function.
Study Details:
The aim of the study is to follow OSA patients at multiple centers over several years, comparing two MAD adjustment methods. Participants will undergo routine fitting and imaging.
Outcome:
The study aims to reduce dental and jaw changes and to improve MAD treatment and patient outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults ≥ 18 years of age
Patients with a diagnosis of OSA
Patients with an apnea-hypopnea index (AHI) of 5 until 30 events per hour
Patients initially treated with MAD
Disqualifiers
Patients under 18 years of age
Patients without a diagnosis of mild to moderate OSA
Patients undergoing other treatments for OSA
Patients previously undergone MAD treatment (this also includes over the counter boil and bite MADs)
Trial population
The participants of the research will be recruited from the Department of Oral and Maxillofacial Surgery at 'Isala Hospital Zwolle' and from the orthodontic practice 'Orthodontisten Heemstede', both located in the Netherlands.
Trial design
Cohort
Prospective
Treatments tested in this trial
Mandibular Advancement Device
DeviceMADs are custom-fitted oral appliances designed to reposition the mandible (lower jaw) forward during sleep, which helps to keep the airway open by preventing upper airway collapse.
Treatment groups
Trial outcomes
Primary outcomes
Dental occlusal measurements
* Overbite (mm): the vertical overlap of the upper and lower teeth. * Overjet (mm): the horizontal overlap of the upper and lower teeth. * Maximal protrusion (mm): the most protrusive position of the mandible, independent of tooth contact. * Maximal retrusion (mm): the most retrusive position of the mandible, independent of tooth contact. * Protrusive range (mm): the distance between the most protrusive and most retrusive position of the mandible. * Maximal mouth opening (mm): the maximum distance between the upper and lower incisors when the mouth is fully opened.
Molar and canine relationships
* Molar relationships (in premolar width equivalents): the relative position of the upper and lower molars. * Canine relationships (in premolar width equivalents): the relative position of the upper and lower canines.
History of orthodontic treatment
• Previous orthodontic treatment (braces/ premolar extractions)
Secondary outcomes
Cephalometric dentofacial measurements
• Dentofacial profile: Pro- and inclination (degrees) • Sagittal facial projection: SNA (degrees), SNB (degrees), and ANB (degrees)
Cephalometric facial and mandibular measurements
• Facial height and divergence: Ar-Go⌃Me (mm), S-N⌃Ar (mm), Na-Me (mm), MP⌃S-Na (mm), and S-Go (mm) • Mandibular dimensions: Go-Gn (mm) and Ar-Go (mm) • Mandibular plane and hyoid point: MP-Hy (mm) • Hyoid point and posterior pharyngeal wall: Hy-PAS (mm)
Cephalometric ratios and divergence
• Facial height and divergence: Ar-Go/N-Me (%)
Other outcomes
Quality of Life (QoL)
* Assessment Tool: Epworth Sleepiness Scale (ESS) * Measurement Parameters: Daytime sleepiness, fatigue levels, and overall life satisfaction related to sleep quality
Cognitive Function
* Assessment Tool: Mini-Mental State Examination (MMSE) * Measurement Parameters: Attention, memory, orientation and executive function
Sleep Quality
* Assessment Tool: Pittsburgh Sleep Quality Index (PSQI) * Measurement Parameters: Sleep latency, duration, efficiency, disturbances, and overall sleep quality
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Amsterdam UMC, location VUmc
Lead sponsor
Academic Centre for Dentistry in Amsterdam
Collaborator
This trial is not recruiting at the moment. You can still explore other options: